Cargando…

The Use of Bromocriptine for Peripartum Cardiomyopathy after Twin Delivery via Oocyte Donation

Peripartum cardiomyopathy (PPCM) is rare but life-threatening. We herein report the case of a 48-year-old woman with PPCM after oocyte donation and delivery of twins. Two weeks after delivery, she suffered from severe symptoms of heart failure [orthopnea, New York Heart Association (NYHA) class IV,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morikawa, Nagisa, Nakayoshi, Takaharu, Yoshimura, Hanae, Watanabe, Megumi, Kumanomido, Jun, Furusho, Aya, Fukui, Daisuke, Eto, Kazuko, Nishida, Norifumi, Nishihara, Michihide, A. Kamiya, Chizuko, Fukumoto, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421160/ https://www.ncbi.nlm.nih.gov/pubmed/30568125 http://dx.doi.org/10.2169/internalmedicine.1537-18

Ejemplares similares

Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
por: Simon, Rebecca, et al.
Publicado: (2018)

Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy
por: Chopra, Sandeep, et al.
Publicado: (2012)

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2017)

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018)

A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy
por: Badianyama, Marheb, et al.
Publicado: (2021)

The role of IL-6 in pathogenesis of abdominal aortic aneurysm in mice
por: Nishihara, Michihide, et al.
Publicado: (2017)

Peripartum Cardiomyopathy Presenting with Predominant Left Ventricular Diastolic Dysfunction: Efficacy of Bromocriptine
por: Ballo, Piercarlo, et al.
Publicado: (2012)

Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports
por: Meyer, Gerd Peter, et al.
Publicado: (2010)

Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report
por: Hakata, Saya, et al.
Publicado: (2019)

Editorial: How do genetic components play a role in peripartum cardiomyopathy?
por: Kamiya, Chizuko A., et al.
Publicado: (2015)

Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high‐dose bromocriptine therapy
por: Horn, Patrick, et al.
Publicado: (2017)

Role of Macrophage Socs3 in the Pathogenesis of Aortic Dissection
por: Ohno‐Urabe, Satoko, et al.
Publicado: (2018)

Involvement of B Cells, Immunoglobulins, and Syk in the Pathogenesis of Abdominal Aortic Aneurysm
por: Furusho, Aya, et al.
Publicado: (2018)

MRTF-A promotes angiotensin II-induced inflammatory response and aortic dissection in mice
por: Ito, Sohei, et al.
Publicado: (2020)

Genetic Deletion of Socs3 in Smooth Muscle Cells Ameliorates Aortic Dissection in Mice
por: Hirakata, Saki, et al.
Publicado: (2020)

High Salt Intake Worsens Aortic Dissection in Mice: Involvement of IL (Interleukin)-17A–Dependent ECM (Extracellular Matrix) Metabolism
por: Nishida, Norifumi, et al.
Publicado: (2020)

Peripartum Serial Echocardiographic Findings in a Patient with Life-threatening Peripartum Cardiomyopathy
por: Aoyama, Daisetsu, et al.
Publicado: (2018)

Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump
por: Schroeter, Marco R., et al.
Publicado: (2012)

The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO‐HF retrospective cohort study
por: Tremblay‐Gravel, Maxime, et al.
Publicado: (2018)

Cryoballoon Ablation Induced Hyperkalemia due to Possible Cold Agglutinin Disease
por: Kumanomido, Jun, et al.
Publicado: (2019)

Cytokine Profile of Human Abdominal Aortic Aneurysm: Involvement of JAK/STAT Pathway
por: Ohno, Tomokazu, et al.
Publicado: (2018)

Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy
por: Haghikia, Arash, et al.
Publicado: (2015)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

Prediction of response to bromocriptine in acromegaly.
por: Atkinson, A. B., et al.
Publicado: (1978)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Central Hyperthermia Treated with Bromocriptine
por: Natteru, P., et al.
Publicado: (2017)

Bromocriptine, a clinical and pharmacological review /
por: Thorner, Michael O.
Publicado: (1980)

Bromocriptine in type 2 diabetes mellitus
por: Shivaprasad, C., et al.
Publicado: (2011)

Management of pituitary tumour apoplexy with bromocriptine in pregnancy
por: Janssen, Nina M, et al.
Publicado: (2012)

Bromocriptine Does Not Alter Speed–Accuracy Tradeoff
por: Winkel, Jasper, et al.
Publicado: (2012)

Bromocriptine and insulin sensitivity in lean and obese subjects
por: Bahler, L, et al.
Publicado: (2016)

Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016)

Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)

Identification of Bonding Difficulties in the Peripartum Period Using the Mother-to-Infant Bonding Scale-Japanese Version and Its Tentative Cutoff Points
por: Hashijiri, Koyo, et al.
Publicado: (2021)

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
por: Gaziano, J. Michael, et al.
Publicado: (2012)

Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
Publicado: (2015)

Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline
por: Shibuya, Yuki, et al.
Publicado: (2022)

Dopaminergic Challenge With Bromocriptine in Patients With Severe Brain Injury
por: Celik, JB, et al.
Publicado: (2015)

Efficacy of bromocriptine on glycemic and metabolic control of prediabetic patients
por: Khalilzade, Saied Hossein, et al.
Publicado: (2015)

Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
por: Tang, Yiqun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f21ebk3to0gle1sligiil1o8eh